Broucqsault-Dédrie Céline, De Jonckheere Julien, Jeanne Mathieu, Nseir Saad
Intensive Care Unit, Hôpital Victor Provo, 35 rue de Barbieux - CS 60359 - 59056 Roubaix Cedex, France.
CHU Lille, Clinical Investigation Center - Innovative Technologies, INSERM CIC-IT 1403, F-59000 Lille, France.
PLoS One. 2016 Jan 25;11(1):e0147720. doi: 10.1371/journal.pone.0147720. eCollection 2016.
The analgesia nociception index (ANI) assesses the relative parasympathetic tone as a surrogate for antinociception/nociception balance in sedated patients. The aim of this study is to determine the effectiveness of ANI in detecting pain in deeply sedated critically ill patients.
This prospective observational study was performed in two medical ICUs. All patients receiving invasive mechanical ventilation and deep sedation were eligible. In all patients, heart rate and ANI were continuously recorded using the Physiodoloris® device during 5 minutes at rest (T1), during a painful stimulus (T2), and during 5 minutes after the end of the painful stimulus (T3). The chosen painful stimulus was patient turning for washstand. Pain was evaluated at T2, using the behavioral pain scale (BPS). The primary objective was to determine the effectiveness of ANI in detecting pain. Secondary objectives included the impact of norepinephrine on the effectiveness of ANI in detecting pain, and the correlation between ANI and BPS.
Forty-one patients were included. ANI was significantly lower at T2 (Med (IQR) 69(55-78)) compared with T1 (85(67-96), p<0.0001), or T3 (81(63-89), p<0.0001). Similar results were found in the subgroups of patients with (n = 21) or without (n = 20) norepinephrine. ANI values were significantly higher in patients with norepinephrine compared with those without norepinephrine at T1, and T2. No significant correlation was found between ANI and BPS at T2.
ANI is effective in detecting pain in deeply sedated critically ill patients, including those patients treated with norepinephrine. No significant correlation was found between ANI and BPS.
镇痛伤害感受指数(ANI)可评估相对副交感神经张力,作为评估镇静患者抗伤害感受/伤害感受平衡的替代指标。本研究旨在确定ANI在检测深度镇静的危重症患者疼痛方面的有效性。
这项前瞻性观察性研究在两个内科重症监护病房进行。所有接受有创机械通气和深度镇静的患者均符合条件。在所有患者中,使用Physiodoloris®设备在静息5分钟(T1)、疼痛刺激期间(T2)以及疼痛刺激结束后5分钟(T3)持续记录心率和ANI。选择的疼痛刺激是患者翻身至洗脸台。在T2时使用行为疼痛量表(BPS)评估疼痛。主要目的是确定ANI在检测疼痛方面的有效性。次要目的包括去甲肾上腺素对ANI检测疼痛有效性的影响,以及ANI与BPS之间的相关性。
纳入41例患者。与T1(85(67 - 96))或T3(81(63 - 89))相比,T2时ANI显著降低(中位数(四分位间距)69(55 - 78)),p<0.0001。在使用(n = 21)或未使用(n = 20)去甲肾上腺素的患者亚组中也发现了类似结果。在T1和T2时,使用去甲肾上腺素的患者的ANI值显著高于未使用去甲肾上腺素的患者。在T2时,未发现ANI与BPS之间存在显著相关性。
ANI在检测深度镇静的危重症患者疼痛方面有效,包括使用去甲肾上腺素治疗的患者。未发现ANI与BPS之间存在显著相关性